2009: Year in Review (Continued)
- DexCom Seven Plus approved: Continuous glucose monitoring was not easy to use when it was first approved, and we'll remember 2009 for being a year when massive strides were made on this front. DexCom's SEVEN PLUS is more accurate, easier to use, and infinitely more reliable than the SEVEN, in our view. Read more details in our review on diatribe. We look forward to 2010 when the SEVEN PLUS will be integrated with two insulin pumps, Insulet's Omnipod and Animas' 2020 and One Touch Ping.
Smiths Medical exits pump diabetes device market: Smiths Medical, maker of the Deltec Cozmo insulin pump, officially exited the insulin pump market last March. Such a move is highly unusual but indicative of new financial pressures on pump companies. Smiths will continue to support current Cozmo users, but no new units will be sold. The Cozmo was a favorite for children, and the brand garnered a small but loyal following. In a conference call hosted by the company, management said its decision was partly due to the overwhelming push toward pump/CGM integration, an investment it was not willing to make. Although many were sad to see the Cozmo go, the company's decision highlights the promising trend toward pump/CGM integration. That said, it also underscores the huge expense pump companies make to invent new technology for patients.
Medingo Solo MicroPump approved by FDA: Where one company has exited, another has entered! Medingo's Solo MicroPump received FDA approval to be sold in the U.S. last August, just a few months after Deltec left the market. The Solo is a tubeless patch pump like the OmniPod. The system consists of a three-month reusable pump, insulin reservoir, three-day disposable (cannula-containing) cradle, and a wireless remote. Dosing decisions are made using the remote, but a key advantage is that bolus dosing can also be made from the body of the MicroPump. Further out, the company is designing an integrated CGM system that we assume would be submitted to FDA post-2010.
Bayer Contour USB blood glucose meter approved: Bayer launched a new blood glucose monitor called the Contour USB that makes downloading quite easy and allows doctors and patients to see patterns in their blood glucose numbers. See the November/December 2009 issue of diatribe for our review.
As I mentioned in an earlier post, one of the benefits that made it cost-effective for me to go with the real healthcare (HSA) plan rather than the phony (HRA) plan is that my company is now covering "preventative" medicines at $0 copay. The formulary for these, as stated by CVS/Caremark (my pharmacy benefits provider), covers all test strips, lancets, and control solutions. I dutifully get my doctor to write up prescriptions for all of my testing needs, submit...